Valuation dashboard for Predictive Oncology Inc. (POAI) with P/E N/A, P/B 2.84, EV/EBITDA -0.50 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline.
Analysis Summary
Predictive Oncology Inc. reported revenue of $125284 in the most recent fiscal year, growing at a 5-year CAGR of -36.9%.
Trailing-twelve-month margins: gross margin 7.1%, operating margin -14.8%, net margin -72.4%.
At the current price of $4.91, POAI has negative trailing earnings (P/E not meaningful) and an ROE of -488.50%. Market capitalisation stands at $4M.
Balance sheet quality for POAI: current ratio of 10.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 2.84 |
| EV / EBITDA | -0.50 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| POAI | Predictive Oncology Inc. | $4M | 2.84 | -488.5% | |
| 0R29.L | Intuitive Surgical, Inc. | $135.9B | 74.05 | 11.86 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.1B | 44.13 | 7.62 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.5B | 33.21 | 2.19 | 6.6% |
| BDX | Becton, Dickinson and Company | $49.0B | 54.89 | 2.05 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.81 | 5.23 | 23.9% |
| 0KW4.L | ResMed Inc. | $31.1B | |||
| MDLN | Medline Inc. | $27.6B | 38.36 | 2.44 | 10.8% |
Price
| Price | $4.91 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -488.50% |
| Return on Invested Capital | -57.56% |
| Return on Assets | -440.73% |
| Gross Margin | 7.15% |
| Operating Margin | -1483.87% |
| Net Margin | -7242.42% |
Related companies: AIM · AMIX · BNGO · CYCN · GBS · HSCS · KTTA
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of POAI: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks